These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 15231890)
21. Image-Guided Percutaneous Radiofrequency Ablation of Central Renal Cell Carcinoma: Assessment of Clinical Efficacy and Safety in 31 Tumors. Dai Y; Covarrubias D; Uppot R; Arellano RS J Vasc Interv Radiol; 2017 Dec; 28(12):1643-1650. PubMed ID: 28673657 [TBL] [Abstract][Full Text] [Related]
22. Variables affecting proper system grounding for radiofrequency ablation in an animal model. Goldberg SN; Solbiati L; Halpern EF; Gazelle GS J Vasc Interv Radiol; 2000 Sep; 11(8):1069-75. PubMed ID: 10997473 [TBL] [Abstract][Full Text] [Related]
23. Thermal protection with 5% dextrose solution blanket during radiofrequency ablation. Chen EA; Neeman Z; Lee FT; Kam A; Wood B Cardiovasc Intervent Radiol; 2006; 29(6):1093-6. PubMed ID: 16802079 [TBL] [Abstract][Full Text] [Related]
24. Radiofrequency ablation: an outpatient percutaneous treatment. Dupuy DE Med Health R I; 1999 Jun; 82(6):213-6. PubMed ID: 10402839 [No Abstract] [Full Text] [Related]
25. Percutaneous ultrasound-guided radiofrequency ablation of recurrent renal cell carcinoma in renal allograft after partial nephrectomy. Goeman L; Joniau S; Oyen R; Van Poppel H Urology; 2006 Jan; 67(1):199. PubMed ID: 16413367 [TBL] [Abstract][Full Text] [Related]
26. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients. Memarsadeghi M; Schmook T; Remzi M; Weber M; Pötscher G; Lammer J; Kettenbach J Eur J Radiol; 2006 Aug; 59(2):183-9. PubMed ID: 16725292 [TBL] [Abstract][Full Text] [Related]
28. Nephron-sparing percutaneous ablation of a 5 cm renal cell carcinoma by superselective embolization and percutaneous RF-ablation. Tacke J; Mahnken A; Bücker A; Rohde D; Günther RW Rofo; 2001 Nov; 173(11):980-3. PubMed ID: 11704906 [TBL] [Abstract][Full Text] [Related]
29. MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months. Merkle EM; Nour SG; Lewin JS Radiology; 2005 Jun; 235(3):1065-71. PubMed ID: 15914485 [TBL] [Abstract][Full Text] [Related]
30. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors. Yin XY; Xie XY; Lu MD; Xu HX; Xu ZF; Kuang M; Liu GJ; Liang JY; Lau WY Cancer; 2009 May; 115(9):1914-23. PubMed ID: 19241423 [TBL] [Abstract][Full Text] [Related]
31. Outcomes of patients with hepatocellular carcinoma referred for percutaneous radiofrequency ablation at a tertiary center: analysis focused on the feasibility with the use of ultrasonography guidance. Kim JE; Kim YS; Rhim H; Lim HK; Lee MW; Choi D; Shin SW; Cho SK Eur J Radiol; 2011 Aug; 79(2):e80-4. PubMed ID: 21514757 [TBL] [Abstract][Full Text] [Related]
32. Thermal damage of the genitofemoral nerve due to radiofrequency ablation of renal cell carcinoma: a potentially avoidable complication. Boss A; Clasen S; Kuczyk M; Anastasiadis A; Schmidt D; Claussen CD; Schick F; Pereira PL AJR Am J Roentgenol; 2005 Dec; 185(6):1627-31. PubMed ID: 16304025 [TBL] [Abstract][Full Text] [Related]